Literature DB >> 9034261

Spectral analysis of systemic arterial pressure and heart rate signals as a prognostic tool for the prediction of patient outcome in the intensive care unit.

H W Yien1, S S Hseu, L C Lee, T B Kuo, T Y Lee, S H Chan.   

Abstract

OBJECTIVES: To evaluate the applicability of changes in spectra of systemic arterial pressure and heart rate signals in the prediction of patient outcome in an adult intensive care unit (ICU). To compare the prognostic predictability of this method with the Acute Physiology and Chronic Health Evaluation II (APACHE II) scoring system.
DESIGN: Prospective data collection from 52 ICU patients.
SETTING: Adult ICU at a large, university-affiliated, medical center. PATIENTS: Consecutive patients who were admitted to the adult ICU due to noncardiac emergencies, and who remained for at least 2 days.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The demographic data, diagnosis, and survival data were recorded for each patient enrolled in this study. For the period between admission and 24 hrs before discharge, the APACHE II score was tabulated daily. Likewise, continuous, on-line, and real-time spectral analysis of systemic arterial pressure and heart rate signals was carried out every day for at least 30 mins at 2200 to 2400 hrs. The averaged power density values during this 30-min recording period of the high-frequency (0.15 to 0.4 Hz), low-frequency (0.08 to 0.15 Hz), and very low-frequency (0.016 to 0.08 Hz) components of systemic arterial pressure and heart rate signals were subsequently computed. Systemic vascular resistance index and cardiac index were also determined daily. We observed a trend of changes in the spectral components of systemic arterial pressure and heart rate signals in patients who eventually survived (n = 25) or died (n = 27). Progressive increases in the power density values of both the low-frequency and very low-frequency components of systemic arterial pressure and heart rate signals appeared to be related to recovery. Conversely, progressive decreases in the power density values of these spectral components was indicative of deterioration and fatality. The predicted outcome based on the trend of changes in the low-frequency and very low-frequency components of systemic arterial pressure and heart rate signals correlated positively with daily APACHE II scores. No direct correlation, however, was indicated by mean systemic arterial pressure, heart rate, systemic vascular resistance index, and cardiac index. We also confirmed that the differential trend of spectral changes in patients who survived or died was not due to circadian rhythm, nor alterations in the responsiveness of the blood vessels to intravenous infusion of dopamine.
CONCLUSION: Power spectral analysis of systemic arterial pressure and heart rate signals offers a reasonable means of monitoring acute, critically ill patients, and may be used as an alternative prognostic tool for the prediction of patient outcome in the ICU.

Entities:  

Mesh:

Year:  1997        PMID: 9034261     DOI: 10.1097/00003246-199702000-00011

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  31 in total

1.  Respiratory induced heart rate variability during slow mechanical ventilation : Marker to exclude brain death patients.

Authors:  Pavel Jurak; Josef Halamek; Vlastimil Vondra; Peter Kruzliak; Vladimir Sramek; Ivan Cundrle; Pavel Leinveber; Mariusz Adamek; Vaclav Zvonicek
Journal:  Wien Klin Wochenschr       Date:  2017-02-24       Impact factor: 1.704

2.  Amelioration of central cardiovascular regulatory dysfunction by tropomyocin receptor kinase B in a mevinphos intoxication model of brain stem death.

Authors:  S H H Chan; J Y H Chan; K S Hsu; F C H Li; E Y H Sun; W L Chen; A Y W Chang
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 3.  Baroreflex functionality in the eye of diffusion tensor imaging.

Authors:  Ching-Yi Tsai; Yan-Yuen Poon; Julie Y H Chan; Samuel H H Chan
Journal:  J Physiol       Date:  2018-11-02       Impact factor: 5.182

4.  Heat shock protein 60 in rostral ventrolateral medulla reduces cardiovascular fatality during endotoxaemia in the rat.

Authors:  Alice Y W Chang; Julie Y H Chan; Jimmy L J Chou; Faith C H Li; Kuang-Yu Dai; Samuel H H Chan
Journal:  J Physiol       Date:  2006-05-04       Impact factor: 5.182

Review 5.  Clinical review: a review and analysis of heart rate variability and the diagnosis and prognosis of infection.

Authors:  Saif Ahmad; Anjali Tejuja; Kimberley D Newman; Ryan Zarychanski; Andrew Je Seely
Journal:  Crit Care       Date:  2009-11-24       Impact factor: 9.097

6.  Extracellular signal-regulated kinase 1/2 plays a pro-life role in experimental brain stem death via MAPK signal-interacting kinase at rostral ventrolateral medulla.

Authors:  Samuel H H Chan; Enya Y H Sun; Alice Y W Chang
Journal:  J Biomed Sci       Date:  2010-03-15       Impact factor: 8.410

7.  Transcriptional up-regulation of nitric oxide synthase II by nuclear factor-kappaB at rostral ventrolateral medulla in a rat mevinphos intoxication model of brain stem death.

Authors:  Julie Y H Chan; Carol H Y Wu; Ching-Yi Tsai; Hsiao-Lei Cheng; Kuang-Yu Dai; Samuel H H Chan; Alice Y W Chang
Journal:  J Physiol       Date:  2007-03-29       Impact factor: 5.182

8.  Autonomic nervous system function and depth of sedation in adults receiving mechanical ventilation.

Authors:  Takeshi Unoki; Mary Jo Grap; Curtis N Sessler; Al M Best; Paul Wetzel; Anne Hamilton; Karen G Mellott; Cindy L Munro
Journal:  Am J Crit Care       Date:  2009-01       Impact factor: 2.228

9.  Brain stem death as the vital determinant for resumption of spontaneous circulation after cardiac arrest in rats.

Authors:  Alice Y W Chang; Julie Y H Chan; Yao-Chung Chuang; Samuel H H Chan
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

Review 10.  Bench-to-bedside review: Beta-adrenergic modulation in sepsis.

Authors:  Etienne de Montmollin; Jerome Aboab; Arnaud Mansart; Djillali Annane
Journal:  Crit Care       Date:  2009-10-23       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.